Will new biosimilars hurt blockbuster autoimmune drug?
New biosimilars may harm the sales of this autoimmune blockbuster.
Read More
Should insurers be urged to publish their data?
Here’s what industry experts think after Cigna’s business model shift.
Four growing diabetes trends
A new University of California, San Diego-led review has interesting findings about diabetes costs, patient care models and medication therapy.
When given the chance, will patients choose cheaper prescription drugs?
A new UC Berkeley study has surprising findings about reference pricing and patient drug selection.
New Cigna program aims to ‘unlock’ the value of healthcare data
Cigna publication project takes a page out of the big pharma and medical technology playbook.
New challenges, opportunities in autoimmune disease treatment
Allegheny Health Network’s Susan Manzi, MD, MPH, discusses the healthcare needs of patients with lupus and other autoimmune disorders.
Five ways to reduce healthcare administrative costs
Administrative costs are a huge burden in healthcare, but there are several process changes that can result in huge savings.
Cognitive computing shakes up healthcare: What execs need to know
The concepts that power cognitive computing and AI have grown to include substantial healthcare advancements.
Health plans explain genetic testing coverage decisions
Today there are nearly 67,000 genetic tests. With so many tests available, it can be difficult for MCOs to determine what to cover.
FDA okays targeted leukemia treatment
FDA approved a targeted new drug to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.
FDA eyes opioids in kids' medicines
An FDA committee will review prescription opioid products containing hydrocodone or codeine to treat coughs in children.
Seven things to know about Express Scripts’ plan to limit opioids
As President Trump declares the opioid epidemic “a national emergency,” a new opioid management program from Express Scripts will limit the number and strength of opioid drugs to first-time patients.
Opinion: 4 reasons to revitalize the Children’s Health Insurance Program
As legislative discussions begin regarding the reauthorization of CHIP, it is imperative to keep in mind how proposed cuts could be detrimental to the health and future of our nation’s children.
Four innovative ways employers can deliver healthcare
A National Business Group on Health survey finds that with costs continuing to rise, employers are shifting control efforts to how healthcare is delivered and paid for.
Report sheds light on regional diabetes prevalence, cost
A new report by the Blue Cross Blue Shield Association has eye-opening findings about diabetes prevalence, severity and cost.
Four reasons payers need to embrace the digital economy
Consumer and provider expectations have changed as a result of the digital economy. Here are four reasons why payers need to start migrating their businesses in that direction.
Groups praise lawsuit against Walgreens, CVS
Pharmacy and medical organizations lauded a new class action lawsuit against CVS Health and Walgreens, alleging the two pharmacy chains colluded with pharmacy benefit managers (PBMs) to drive up the cost of generic drugs.
FDA warns about contaminated drugs, dietary supplements
FDA warned consumers and health care professionals not to use a certain brand of drugs and dietary supplements that are contaminated.
Non-adherence has big impact on Medicaid beneficiaries with HIV
New data presented at the International AIDS Society Conference examines the medical and financial burden of missing pills.
How Cigna reduced opioid use 12% in 12 months
Managed Healthcare Executive (MHE) recently spoke with Cigna’s Chief Medical Officer for Behavioral Health Doug Nemecek, MD, about Cigna’s efforts, outcomes, and how it plans to reach its goal
How medical schools are responding to the opioid epidemic
As the opioid epidemic rages, up-and-coming physicians are seen as part of the solution. Here’s how medical schools are changing their training programs.
Nine new skills needed by health execs
Do you have what it takes to succeed as a healthcare executive? Industry leaders weigh in.
Opinion: Three ways to maximize the benefits of physician assistants
How Phoenix Children’s improved access, value and outcomes through a dedicated focus on advanced practice providers.
Opinion: Medicare for all: Imminent or pipe dream?
As the nation debates the future of our healthcare system, one idea gaining attention is a “Medicare-for-all” single-payer national health insurance plan.
DEA wants to slash opioid production
The Drug Enforcement Administration wants to slash the production of opioid painkillers by 20% in 2018.
Four data analytics areas that promote cost savings
Analytics is an integral component of healthcare no matter what Congress decides, according to one expert. Here are 4 areas of data analytics that health plans can develop that will promote future cost savings.
Medical marijuana update: Top 3 things health execs should know
Here’s what you need to know about medical marijuana laws, and what they mean for the healthcare system.
FDA approves novel leukemia, hepatitis C drugs
FDA approved the first treatment for patients with a certain type of acute myeloid leukemia, as well as 2 new drugs to treat hepatitis C.
Controversy surrounds Exondys 51 approval: What to know
New medicine for Duchenne muscular dystrophy raises questions. Here’s whose covering it and why.
Eight data analytics terms every healthcare executive should know
With so much going on in health IT, it can be difficult to keep track of all the buzzwords. Here’s your quick and easy guide.
